Incyte (INCY) Tax Rate Growth (5y) (2015 - 2026)
Incyte (INCY) Tax Rate Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn |
| 10 | Incyte | 23.83 Bn | 19.81 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,107.00 |
| Dec 31, 2025 | 1,238.00 |
| Sep 30, 2025 | 34,558.00 |
| Jun 30, 2025 | 2,190.00 |
| Mar 31, 2025 | 3,480.00 |
| Dec 31, 2024 | 2,396.00 |
| Sep 30, 2024 | 1,868.00 |
| Jun 30, 2024 | -1,719.00 |
| Mar 31, 2024 | 2,648.00 |
| Dec 31, 2023 | -253.00 |
| Sep 30, 2023 | 2,093.00 |
| Jun 30, 2023 | 2,369.00 |
| Mar 31, 2023 | 6,010.00 |
| Dec 31, 2022 | 6,561.00 |
| Sep 30, 2022 | 726.00 |
| Jun 30, 2022 | 6,266.00 |
| Mar 31, 2022 | 4,063.00 |
| Dec 31, 2021 | -37,586.00 |
| Sep 30, 2021 | 952.00 |
| Jun 30, 2021 | 1,069.00 |